53BP1 participates early in the DNA damage response and is involved in cell cycle checkpoint control. Moreover, the phenotype of mice and cells deficient in 53BP1 suggests a defect in DNA repair (Ward et al., 2003b). Therefore, we asked whether or not 53BP1 would be required for the efficient repair of DNA double strand breaks. Our data indicate that homologous recombination by gene conversion does not depend on 53BP1. Moreover, 53BP1-deficient mice support normal V(D)J recombination, indicating that 53BP1 is not required for “classic” nonhomologous end joining. However, class switch recombination is severely impaired in the absence of 53BP1, suggesting that 53BP1 facilitates DNA end joining in a way that is not required or redundant for the efficient closing of RAG-induced strand breaks. These findings are similar to those observed in mice or cells deficient in the tumor suppressors ATM and H2AX, further suggesting that the functions of ATM, H2AX, and 53BP1 are closely linked.
Skip Nav Destination
Article navigation
24 May 2004
Report|
May 24 2004
53BP1 is required for class switch recombination
In Special Collection:
JCB65: DNA Replication and Repair
Irene M. Ward,
Irene M. Ward
1Division of Oncology Research, Mayo Clinic, Rochester, MN 55905
Search for other works by this author on:
Bernardo Reina-San-Martin,
Bernardo Reina-San-Martin
4Laboratory of Molecular Immunology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10021
Search for other works by this author on:
Alexandru Olaru,
Alexandru Olaru
5Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201
Search for other works by this author on:
Kay Minn,
Kay Minn
1Division of Oncology Research, Mayo Clinic, Rochester, MN 55905
Search for other works by this author on:
Koji Tamada,
Koji Tamada
2Division of Immunology, Mayo Clinic, Rochester, MN 55905
Search for other works by this author on:
Julie S. Lau,
Julie S. Lau
2Division of Immunology, Mayo Clinic, Rochester, MN 55905
Search for other works by this author on:
Marilia Cascalho,
Marilia Cascalho
3Transplantation Biology, Mayo Clinic, Rochester, MN 55905
Search for other works by this author on:
Lieping Chen,
Lieping Chen
2Division of Immunology, Mayo Clinic, Rochester, MN 55905
Search for other works by this author on:
Andre Nussenzweig,
Andre Nussenzweig
6Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Ferenc Livak,
Ferenc Livak
5Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201
Search for other works by this author on:
Michel C. Nussenzweig,
Michel C. Nussenzweig
4Laboratory of Molecular Immunology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10021
Search for other works by this author on:
Junjie Chen
Junjie Chen
1Division of Oncology Research, Mayo Clinic, Rochester, MN 55905
Search for other works by this author on:
Irene M. Ward
1Division of Oncology Research, Mayo Clinic, Rochester, MN 55905
Bernardo Reina-San-Martin
4Laboratory of Molecular Immunology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10021
Alexandru Olaru
5Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201
Kay Minn
1Division of Oncology Research, Mayo Clinic, Rochester, MN 55905
Koji Tamada
2Division of Immunology, Mayo Clinic, Rochester, MN 55905
Julie S. Lau
2Division of Immunology, Mayo Clinic, Rochester, MN 55905
Marilia Cascalho
3Transplantation Biology, Mayo Clinic, Rochester, MN 55905
Lieping Chen
2Division of Immunology, Mayo Clinic, Rochester, MN 55905
Andre Nussenzweig
6Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Ferenc Livak
5Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201
Michel C. Nussenzweig
4Laboratory of Molecular Immunology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10021
Junjie Chen
1Division of Oncology Research, Mayo Clinic, Rochester, MN 55905
Address correspondence to Junjie Chen, 1306 Guggenheim, Mayo Clinic, 200 First St., SW, Rochester, MN 55905. Tel.: (507) 538-1545. Fax: (507) 284-3906. email: [email protected]
Abbreviations used in this paper: CSR, class switch recombination; DSB, double strand break; HR, homologous recombination; I, intronic; IR, ionizing radiation; NHEJ, nonhomologous end joining; PFGE, pulse field gel electrophoresis; TCR, T cell receptor.
Received:
March 02 2004
Accepted:
April 02 2004
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2004
J Cell Biol (2004) 165 (4): 459–464.
Article history
Received:
March 02 2004
Accepted:
April 02 2004
Citation
Irene M. Ward, Bernardo Reina-San-Martin, Alexandru Olaru, Kay Minn, Koji Tamada, Julie S. Lau, Marilia Cascalho, Lieping Chen, Andre Nussenzweig, Ferenc Livak, Michel C. Nussenzweig, Junjie Chen; 53BP1 is required for class switch recombination . J Cell Biol 24 May 2004; 165 (4): 459–464. doi: https://doi.org/10.1083/jcb.200403021
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement